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Production and hosting by ElsevierNoha Hassanin a,⇑, Alkhateeb Alkemary baDepartment of Cardiology, Cairo University, Cairo
bDepartment of Internal Medicine and Nephrology, Cairo University, Cairo
a,b EgyptBackground: Pulmonary hypertension (PH) is one of the most important comorbidities in patients undergoing
hemodialysis (HD). The goal of the present work is to determine the possible etiologic factors for its occurrence.
Methods: The prevalence of PH was estimated by Doppler echocardiography in a cohort of 100 patients aged
49.3  13.9 years on regular HD. Mean pulmonary artery pressure was estimated from pulmonary acceleration time
by Mahan’s regression equation. Pulmonary vascular resistance and pulmonary capillary wedge pressure were cal-
culated. We focused on the effect of HD on left and right ventricle diastolic and systolic function. Right ventricle
systolic function was assessed by tricuspid annular systolic excursion and pulsed Doppler myocardial performance
index. Since impaired endothelial function was postulated as an underlying cause of PH, we studied the effects of
HD on brachial artery endothelial function.
Results: The current study found that pulmonary hypertension was prevalent in 70% of patients on dialysis. Left
atrium diameter, left ventricle mass indexed to body surface area, and mitral E/E0 were increased in the dialysis
group (4.4  0.2 cm, 126.5  24.6 g/m2, and 16.9  4.4, respectively, p < 0.001 for all). Pulmonary artery systolic pres-
sure was positively correlated to duration of dialysis and negatively correlated to glomerular filtration rate
(p < 0.001 and r = 0.991). Pulmonary vascular resistance was significantly increased in dialysis patients (1.9  0.2
Wood units vs. 1.2 Wood units in controls, p < 0.001). Endothelial dysfunction, defined as brachial artery flow medi-
ated dilatation <6%, was found in 46% of dialysis group.
Conclusion: Increased pulmonary artery systolic pressure in the HD population could be attributed to left atrium
dilatation and left ventricle diastolic dysfunction. Pulmonary vascular resistance was significantly increased in dial-
ysis group. This might be explained by impaired endothelial nitric oxide synthesis that not only caused systemic
vasoconstriction but also affected the pulmonary vasculature.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
PH pulmonary hypertension
HD hemodialysis
PA pulmonary artery
PAP pulmonary artery pressure
PVR pulmonary vascular resistance
TRV tricuspid regurgitant velocity
TVI RVOT right ventricular outflow tract time-velocity
integral
PCWP pulmonary capillary wedge pressure
FMD flow mediated dilatation
LV left ventricle
GFR glomerular filtration rate
MDRD formula Modification of Diet in Renal Disease
formula
WHO FC World Health Organization functional class
LVEF left ventricular ejection fraction
LVMI left ventricular mass index
EACVI European Association of Cardiovascular Imaging
ASE American Society of Echocardiography
LA left atrium
LAVI left atrium volume index
RV right ventricle
TDI tissue Doppler imaging
TAPSE tricuspid annular plane systolic excursion
MPAP mean pulmonary artery pressure
AT pulmonary acceleration time
SPAP pulmonary artery systolic pressure
RAP right atrium pressure
TTE transthoracic echocardiography
LVH left ventricle hypertrophy
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Pulmonary hypertension (PH) is a complexhemodynamic alteration that may result from
disparate causes. In the 2008 classification by the
World Health Organization and in more recent
guidelines by the European Society of Cardiology,
for the first time attention was given to PH in dial-
ysis patients classified in the fifth category gather-
ing various forms of PH with unclear etiology [1].
The high prevalence of PHwas attributed to high
cardiac output secondary to the presence of
arteriovenous fistula, anemia, and/or and to left
ventricular (LV) disorders [2]. Moreover, sleep
apnea, accumulation of endogenous inhibitors of
nitric oxide synthase, insult to pulmonarymicrocir-
culation attributable to exposure to dialysis
membranes is likely to contribute to the unique
propensity of dialysis patients to PH [3]. Our aim
was to study the contribution of left and right
ventricle dysfunction to pulmonary hypertension.
The second aim was to show that simple echocar-
diographic equations can be used to assess systolic,
mean pulmonary artery pressure and pulmonary
vascular resistance that might help in evaluation
and risk stratification of patients on dialysisMPI myocardial performance index
AVF arteriovenous fistula
TPG transpulmonary pressure gradient
RHC right heart catheterization
CKD chronic kidney diseasePatients and methods
Forty healthy controls and 100 adult patients
aged 49.3  13.9 years on regular hemodialysis
(HD) for at least 12 months (range, 12–80 months)
were referred from the Nephrology Department of
Cairo University, Cairo, Egypt for echocardiogra-
phy. Written consent was given by all the partici-
pants. The study protocol was approved by the
Ethics Committee at Cairo University Hospital.
Inclusion criteria were: adults aged P18 years,
stage 4 or 5 chronic kidney disease (CKD) defined
as serum creatinineP2.26 mg/dL or glomerular fil-
tration rate (GFR)630 mL/min/1.73 m2 assessed by
MDRD4-formula [4] on HD, and in World Health
Organization functional class P II with dyspnea
unexplained by other causes. Exclusion criteria
were: pregnancy; LV ejection fraction (EF) <50%;
mitral or aortic regurgitation > Grade 2; myocardi-
tis; endocarditis; pericarditis; severe chronic
obstructive pulmonary disease; lung fibrosis; and
known pulmonary artery hypertension-reducing
medication with prostanoids, endothelin receptor
antagonists, or phosphodiesterase-5 inhibitors.
Patients were subjected to history taking, phys-
ical examination, and demographic parameters,
including age, sex, and body mass index.Echocardiography studies were performed
using a commercial scanner (iE33; Philips Medical
System, Andover, MA, USA) according to the
recommendations of the American Society of
Echocardiography [5].
M-mode echocardiography
LV dimensions, wall thickness and functions
were studied. LV mass was calculated using the
Devereux formula [6]:
LV massðgÞ ¼ 0:8 1:04 ½LVIDþ PWTþ IVST3
 ½LVID3 þ 0:6 g; ð1Þ
where LVID is the left ventricle internal dimension,
PWT is the posterior wall thickness, IVST is the inter-
ventricular septal thickness, 1.04 is the specific gravity
of the myocardium, and 0.8 is the correction factor.
The LV mass index (LVMI, g/m2) was defined as LV
mass divided by body surface area (m2). The reference
ranges used to define LV hypertrophy (LVH) was LVMI
>115 g/m2 and 95 g/m2 for men and women, respectively
[5]. We tried refinements in image processing according
Figure 1. Pulmonary acceleration time (a) 70 ms in dialysis patient and (b) 141 ms in a control participant.
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ASE/European Association of Cardiovascular Imaging
(EACVI) guidelines in order to measure the actual
visualized thickness of the ventricular septum and
other chamber dimensions as defined by the actual
tissue–blood interface, rather than the distance between
the leading edge echoes, which had previously been
recommended [7].
Left atrium study
Linear dimension of the left atrium (LA) is the
anteroposterior diameter in the parasternal
long-axis view using M-mode echocardiography.
From the apical four chamber views maximum
left atrium volumes were calculated using the
area–length method according to the guidelines
of the American Society of Echocardiography.
Maximum volumes were divided by body surface
area to calculate the LA volume index (LAVI) [5]
Right ventricle study
Our study was designed to evaluate the effect of
HD on right ventricular (RV) diastolic function and
systolic functions. Distal RV outflow diameter was
studied using the inner-edge-to-inner-edge
method according to the recent guidelines just
proximal to the pulmonary valve at end-diastole
[5]. Tricuspid inflow velocities were recorded using
pulsed wave Doppler with the sample volume
placed at the tip of the tricuspid valve tips from
the apical four-chamber view. Peak E and A wavevelocities and E/A ratio were studied. The cut off
for diagnosis of impaired RV diastolic function is
<0.8 [5]. The average early diastolic velocity of the
tricuspid annulus E0 was obtained by tissue
Doppler imaging (TDI) of the septal and lateral
sides of the tricuspid annulus. Right-sided E/E0
was used to assess filling pressure of the RV.
RV systolic function was assessed by RV
myocardial performance index (Tei index) using
pulsed Doppler method and tricuspid annular
plane systolic excursion (TAPSE) using M-mode
echocardiography.
Pulsed Doppler echocardiography
Mitral inflow velocities were recorded using
pulsed wave Doppler with the sample volume
placed at the tip of the mitral valve tips from
the apical four-chamber view. From the mitral
valve inflow velocity curve, the following
measurements were made: peak E, A wave veloc-
ities, and E/A ratio. The average early diastolic
velocity of mitral annulus E0 was obtained by
TDI of the septal and lateral sides of the mitral
annulus. Pulmonary capillary wedge pressure
(PCWP) was calculated according to the formula:
1:24 ðE=E0Þ þ 1:9 ½8: ð2ÞColor Doppler flow propagation velocity
Color Doppler M-mode imaging can be applied
in the apical views to assess the velocity and rate
Figure 2. (a) Right ventricle systolic pressure with the Bernoulli equation formula. (b) Right atrial pressure calculated on the basis of inferior
vena cava diameter.
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LV apex. In this way, the early diastolic filling
wave by color m-mode, which appears in red, as
blood flow from the mitral valve level to the LV
apex can be identified. The slope of this early dias-
tolic color m-mode wave (Vp), is rapid (vertical) in
patients with normal diastolic function due to
rapid diastolic suction in which blood quickly flow
from mitral valve to LV apex. However, in the
presence of increasingly impaired relaxation, this
slope becomes flatter, reflecting increasingly
impaired LV relaxation E/Vp ratio has therefore
been developed and correlates to mean LA pres-
sure [9,10]. Moreover, VP >50 cm/s is considered
normal and E/Vp ratio P2.5 predicts PCWP
>15 mmHg with reasonable accuracy [11].
Mean pulmonary artery (PA) pressure (MPAP)
was estimated using pulmonary acceleration time
AT measured by pulsed Doppler of the PA in sys-
tole, whereby (Fig. 1):
mean PA pressure ¼ 79 ð0:45ATÞ ½12 ð3ÞContinuous Doppler echocardiography
Echo–Doppler studies can provide an estimate
of the pulmonary artery systolic pressure calcu-
lated on the basis of the tricuspid regurgitation
jet velocity in absence of pulmonary stenosis. Pul-
monary artery systolic pressure (SPAP: assumed
to be equal to right ventricle systolic pressure)
can be estimated with the Bernoulli equation
formula:
4 TRv2þ RAP; ð4Þ
where v is the maximum velocity of the tricuspid valve
regurgitant jet, measured by continuous wave Doppler,added to the estimated right atrial pressure (RAP) calcu-
lated on the basis of the inferior vena cava diameter and
the extent of its inspiratory collapse [13] (Fig. 2).
Pulmonary vascular resistance (PVR) was
obtained using the equation:
PVR ¼ TRV=TVIRVOT 10þ 0:16 ð5Þ
where TRV is peak tricuspid regurgitant velocity and TVI
RVOT is right ventricular outflow tract time–
velocity integral. A normal PVR is <1.5 Wood units
(120 dynes cm/s2), and significant pulmonary hyperten-
sion is defined as a PVR >3 Wood units (240 dynes cm/s2).
The estimation of PVR is not adequately established to
be recommended for routine use but may be considered
in patients in whom SPAP may be exaggerated by high
stroke volume or misleadingly low (despite increased
PVR) by reduced stroke volume [14,15].
Brachial flow-mediated vasodilatation
An iE33 Philips color Doppler ultrasound scan-
ner, Andover, MA, USA was used in this study.
All imaging procedures were conducted by pro-
fessionally trained operators. The brachial artery
diameter was measured using the ultrasound
scanner with a 7-MHz linear array probe [16]. In
the dialysis group, the brachial artery diameter
was measured on the nonarteriovenous fistula
side, whereas the diameter of the right brachial
artery was measured in the control groups. The
longitudinal section of the brachial artery 5 cm
above the elbow was scanned with the upper
extremity abducted to 15 and the forearm supi-
nated. Diastolic diameter of the resting brachial
artery was recorded as the baseline diameter.
The blood pressure was raised to 220 mmHg (to
exceed the systolic blood pressure by at least
50 mmHg), and the deflation was sustained for
Table 1. Baseline characteristics.
Clinical parameters Patients on hemodialysis (n = 100) Control (n = 40) p
Age (y) 49.3  13.9 49.3  14 NS
Sex 52F/47 M 20F/20 M NS
Body mass index (kg/m2) 25.0  1.6 26  7.2 NS
Waist circumference (cm) 114.4  14.5 90.6  11.7 <0.001
Systolic blood pressure (mmHg) 142.9  9.5 129.4  8.0 <0.001
Diastolic blood pressure (mmHg) 90.1  7.8 78.4  6.9 <0.001
Duration of dialysis (mo) 38.7  20 — —
Underlying renal disease, n (%)
Chronic glomerulonephritis 10 (10)
Diabetic nephropathy 33 (33.3)
Hypertensive nephrosclerosis 16 (16.7)
Polycystic kidney syndrome 13 (13.3)
Others 26 (26.7)
Laboratory data
Hemoglobin (g/dL) 9.7  0.9 14.5  0.3 <0.001
Serum creatinine (mg/dL) 7.8  1.1 0.6  0.0 <0.001
Serum potassium (mEq/L) 5.4  0.2 3.9  0.2 <0.001
Serum calcium (mg/dL) 8.3  0.8 9.3  0.1 <0.001
Residual GFR (mL/min/1.73 m2) 21.9  4.9 96.8  2.5 <0.001
Continuous data are expressed as mean  standard deviation.
GFR = glomerular filtration rate; NS = not significant.
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lated as:
ðdiameter after arterial occlusion
 baseline diameterÞ=baseline diameter 100: ð6Þ
Normal endothelial functions were defined as
flow mediated dilatation (FMD) >6%; thus, FMD
66% was considered to indicate endothelial dys-
function [17].
Statistical analysis
Data were analyzed using IBM SPSS advanced
statistics version 22 (SPSS Inc., Chicago, IL,
USA). Numerical data were expressed as mean
and standard deviation or median and range as
appropriate. Qualitative data were expressed as
frequency and percentage. Chi-square test was
used to examine the relation between qualitative
variables. For quantitative data, comparison
between two groups was done using Student t
test. Pearson product–moment was used to esti-
mate correlation between numerical variables.
All tests were two-tailed. A p value <0.05 was con-
sidered significant.Results
From September 2014 to June 2015, 100 consecu-
tive patients with severe CKD stage 4 or 5 on reg-
ular HD and 40 age- and sex-matched controls
were screened by transthoracic echocardiographyfor study participation. Baseline characteristics of
the study population are shown in Table 1.
Laboratory investigations showed a significant
increase in serum creatinine and potassium and
decrease in blood hemoglobin, calcium and GFR
in the HD group compared with the control group
(p < 0.001 for all).
Of the 100 patients, 66 patients had E/E0 ratios
>15 (which identifies an abnormally elevated LV
filling pressure) [18]. Using Pearson correlation
an elevated E/E0 ratio >15 was negatively corre-
lated to GFR (correlation coefficient r
value = 0.991), positively correlated to SPAP
and LA diameter (p < 0.001, for all). Color
M-mode propagation velocity was significantly
decreased in dialysis group (45.3  3.2 cm/s vs.
66  2.3 cm/s in control, p < 0.001), E/Vp ratio
was 1.6 and 1.1, p < 0.001 in dialysis and controls
respectively. Moreover, E/Vp was P1.5 in 52% of
dialysis population (Fig. 3).
Seventy percent of the dialysis group had
LVH. LVMI was positively correlated to
systolic blood pressure (p < 0.001) and negatively
correlated to hemoglobin level (r = 0.6). Left
atrium diameter and indexed maximum volumes
were significantly increased in dialysis group
(4.3  0.5 cm and 33.5  3.0 mL/m2 vs.
3.4  0.3 cm and 24.2  2.4 mL/m2 in controls
(p < 0.001 for both; Fig. 4). Other echocardio-
graphic parameters are presented in Table 2.
Pulmonary artery systolic and mean pressure
values were significantly elevated in dialysis
Figure 3. Transmitral flow propagation velocity (Vp): Placing the color Doppler sample volume from the mitral annular level to the left
ventricular (LV) apex, the more rapid the LV relaxation, the faster blood travels from the mitral annular level to the LV apex, and hence the more
vertical the color Doppler mitral inflow M-mode and the more rapid the Vp slope (a). By contrast, the more impaired the LV relaxation, the
slower blood flows from the mitral annular to the LV apex, hence a flatter Vp slope (b).
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respectively). All patients with diagnostic criteria
of pulmonary hypertension had PCWP
P15 mmHg.
Pulmonary artery systolic pressure was posi-
tively correlated to duration of dialysis (r = 0.9;
Fig. 5) and negatively correlated to GFR
(p < 0.001 and r = 0.9; Fig. 6). Moreover, LA diam-
eter and mitral E/E0 are positively correlated to
SPAP (p < 0.001).
Echo-derived PVR was significantly increased in
dialysis patients (1.9  0.2 Wood units vs. 1.2
Wood units in controls, p < 0.001).Tricuspid E/A ratio and E/E0 values were 0.9 and
5.7 in the dialysis group vs. 1.3 and 3.8 in controls,
respectively (p < 0.001 for both). RV E/A ratio <0.8
was found in 40% of the dialysis group.
RV myocardial performance index (MPI)
defined as the ratio of total isovolumic time
divided by ejection time was studied using the
pulsed Doppler method. Ejection time is deter-
mined from the parasternal short-axis view at
the pulmonary valve, based on the pulsed wave
Doppler signal at the right ventricular outflow
tract while isovolumic intervals are derived based
on the pulsed wave Doppler envelope of the
Table 2. Echocardiographic parameters of the study groups.
Echocardiographic parameters Dialysis group (n = 100) Control group (n = 40) p
M-mode & 2D
LVEDD (cm) 5.1  0.5 4.6  0.4 <0.001
LV EF (%) 54.3  1.5 63  0.7 <0.001
LVMI (g/m2) 126.5  24.6 81.8  11 <0.001
LADs (cm) 4.3  0.5 3.4  0.3 <0.001
LAVI max (mL/m2) 33.5  3.0 24.2  2.4 <0.001
Mitral inflow velocities
E, cm/s 69.9  19.8 73.9  3.6 0.056
A, cm/s 72  14.6 60.2  1.6 <0.001
E/A ratio 0.9  0.1 1.2  0.02 <0.001
LV diastolic filling pressure
E/E0 ratio 16.9 5.5 <0.001
Data are presented as mean  standard deviation.
A = late diastolic transmitral flow velocity; E = early diastolic transmitral inflow velocity; E/A = ratio of early to late transmitral flow velocity;
EDD = end-diastolic diameter; EF = ejection fraction; LADs = left atrial diameter at end-systole; LAVI = left atrium maximum volume indexed to body
surface area; LVMI = left ventricle mass index; 2D = two dimensional.
FU
LL
 L
EN
G
TH
 A
RT
IC
LE
0
10
20
30
40
50
60
70
0 20 40 60 80 100
PA
SP
Duraon of dialysis
Figure 5. Duration of dialysis in months and pulmonary artery
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PULSED DOPPLER ECHOCARDIOGRAPHY IN ESRD PATIENTStricuspid flow (Fig. 7). The problem with this
method is that the measurements are taken from
two cardiac cycles and care must be taken to
choose beats with similar R–R intervals for a more
accurate assessment of the MPI. Right ventricle
MPI was 0.42 in dialysis group versus 0.2 in
controls (p < 0.001).0
10
20
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60
70
0 5 10 15 2
Figure 6. Glomerular filtration rate (GFR) in ml/min/1.73 m2 and pulmonTAPSE was <20 mm in 65% of the dialysis group.
TAPSE was 23 mm and 19 mm in controls and
dialysis groups respectively (p < 0.001; Fig. 8).
Endothelial dysfunction
Endothelial dysfunction, defined as FMD 66%
was present in 46 of the 100 patients (46%). The
baseline, postocclusion diameters of the brachial
artery, and FMD were 3.9  0.8 mm,
4.1  0.8 mm, and 5.1%, respectively in dialysis
patients versus 3.8  0.7 mm, 4.5  0.8 mm, and
18.4%, respectively, in the control group with nor-
mal endothelial function (Fig. 9).Discussion
PA pressure may be increased by high cardiac
output resulting from the arteriovenous fistula
(AVF) and/or concomitant renal anemia, as well
as from fluid overload [2,19,20]. Critics of this0 25 30 35
ary artery systolic pressure (PASP) in mm Hg among dialysis group.
Figure 7. Right ventricle myocardial performance index by pulsed Doppler envelope. TCO-ET/ET where TCO is tricuspid valve closure-to-
opening time and ET is ejection time.
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Figure 9. Flow-mediated dilatation in control (a) and dialysis patient (b).
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PULSED DOPPLER ECHOCARDIOGRAPHY IN ESRD PATIENTShypothesis argue that increased venous return
alone would be incapable of increasing PA pres-
sure due to the compliant nature of the normal
pulmonary vascular circulation, suggesting that
either the pulmonary vasculature is noncompliant
in these patients or other mechanisms are
involved. Acarturk et al. [21] showed no significant
difference in AVF flow between patients with PH
and those without in a cross-sectional study.
Diastolic and systolic left heart dysfunctions are
frequent in this setting as indicated by the high
rate of post capillary PH in those patients. Some
studies concluded that diastolic dysfunction was
the main cause of postcapillary pulmonary hyper-
tension in those patients [22].
Although it may be difficult to distinguish
between diagnosis of precapillary PH and heart
failure with preserved ejection fraction, right heart
catheterization postdialysis was able to unmask
precapillary PH initially masked by fluid overload
in four of 25 patients of primarily postcapillary PH[22]. There are several mechanisms that may con-
tribute to the development of precapillary PH in
patients undergoing long-term dialysis, including
impaired endothelial function [23] and increased
levels of endothelin-1 [24].
Mechanisms responsible for the increase in PA
pressure in left heart disease are multiple and
include the passive backward transmission of the
pressure elevation (postcapillary passive PH). In
these cases the transpulmonary pressure gradient
(TPG = mean PA pressure mean PCWP) and
PVR are within the normal range. In other circum-
stances the elevation of PAP is greater than that of
PCWP (increased TPG) and an increase in PVR is
also observed (postcapillary reactive PH) [25].
Although not documented by right heart catheter-
ization, the current study showed a high rate of
postcapillary PH in dialysis patients. Since we
have excluded patients with reduced LV EF, the
main diagnosis in our cohort probably is LV dias-
tolic dysfunction.
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PCWP may be a poor indicator of LV end-
diastolic pressure; in one study about half of the
patients diagnosed with PH based on PCWP
<15 mmHg had elevated LV end-diastolic pres-
sures on left heart catheterization [26], In accor-
dance with other studies [27], we found that PH
is prevalent in 70% of dialysis patients with signif-
icant relationship between duration of dialysis
and PAP. By contrast, Mousavi and colleagues’
[28] study on 62 patients, found that prevalence
of PH was 51.6%, and reduction in serum albumin
and anemia were considered as contributing
causes. Moreover, they failed to reach a significant
relationship between duration of dialysis and PA
pressure [28]. Concordant with others [29] LA
diameter and GFR were independent determi-
nants (r = 0.991, p < 0.001 for all) of PA pressure.
The current study found that PVR was signifi-
cantly increased in the dialysis group. This might
be explained by impaired endothelial nitric oxide
synthesis and elevated levels of endothelin that
cause systemic vasoconstriction but are also likely
to affect the pulmonary vasculature [30].
Methods of assessing vascular endothelial func-
tion can be classified as invasive, noninvasive, or
microvascular. Sonography is the most widely
used noninvasive method for clinical assessment
of flow-mediated dilatation [16]. It was found that
FMD of brachial artery on the nonarteriovenous
fistula side of dialysis patients may closely reflect
peripheral vascular endothelial function. More-
over, uremic patients have evidence of endothelial
dysfunction that is accelerated by HD and the
effects were associated with the duration of HD
[31]. The current study showed significantly
reduced FMD in dialysis patients compared to
controls (5.1% vs. 18.4% in controls, p < 0.001).
Impaired endothelial function might be the
underlying cause of elevated PVR in dialysis
patients. Although not verified in dialysis patients
it was found that a significant inverse correlation
between brachial FMD and pulmonary vascular
resistance studied using right heart catheteriza-
tion in patients with heart failure with preserved
EF [32].
There are conflicting data concerning the LV EF
in patients on HD. Paneni et al. [33] found that the
EF was significantly lower in HD patients than in
peritoneal dialysis patients and controls
(56.1  8.6%, 62.4  9.8%, and 68.3  5.7%,
p = 0.001, respectively). However Said et al. [34]
found no difference in the LV EF between the
HD group and the control group (62.50  11.6%
and 64.54  15.20%, p = 0.525, respectively). Thecurrent study found that EF was significantly
lower in HD (54.3  1.5 vs. 63  0.7, p < 0.001).
The LVH is highly prevalent in CKD and is associ-
ated to a clearly unfavorable prognosis. More than
two-thirds of the patients undergoing dialysis
with LVH die of congestive heart failure or sudden
death [35]. Prevalence of LVH varies from 16% to
31% in individuals with CKD and glomerular fil-
tration >30 mL/min 60–75% in those starting renal
substitution therapy and up to 70–90% in patients
undergoing regular dialysis therapy [36]. Concor-
dantly, we found that LVH was prevalent in 80%
of patients on regular HD.
As LA diameter is a strong predictor of diastolic
dysfunction, the findings suggest that, in this
group of patients, diastolic dysfunction may be a
more relevant mechanism for PH. Recent direc-
tives recommend that the adequate quantification
of the LA size be obtained by the estimate of the
chamber volume in the two-dimensional mode
and not by the traditional measurement of the
anteroposterior diameter in the M-mode [5,37].
In the ASE/EAE guidelines, the upper normal
limit for max LAVI is 34 mL/m2. This reference
value is not only derived from population studies,
but it is also based upon an estimation of risk
related to chamber size, and from expert opinion
[5]. We found that 40% of dialysis group had LAVI
P34 mL/m2. It was found that indexed LA volume
>32 mL/m2 provided complementary information
to the traditional clinical and echocardiographic
data, including EF, E/E0 ratio, and LV mass [38].
As the LV diastolic function seems to be chroni-
cally compromised in most patients undergoing
HD, even in those who are asymptomatic, the
LA volume can offer the opportunity to identify
the individuals at higher risk to present with heart
failure, atrial arrhythmias, and poor clinical evolu-
tion [38].
Palecek et al. [39] had previously found that TDI
E0 appears to be superior to Vp in the detection of
mild to moderate LV diastolic dysfunction. How-
ever, color M-mode propagation velocity Vp was
significantly decreased in the dialysis group
(45.3  3.2 cm/s vs. 66  2.3 cm/s in control,
p < 0.001), E/Vp ratio was 1.6  0.2 and 1.1 in dial-
ysis and controls, respectively. Moreover, E/Vp
was P1.5 in 52% of the dialysis population. The
study did not compare values before and after
dialysis as the load dependency of propagation
velocity was previously reported by some studies
that reported that TDI E0 maximal velocity mea-
sured at the lateral portion of the mitral annulus
appeared to be relatively preload independent
and reproducible. In contrast to E0, septal velocity
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reduction [40]. Ie and Zietse [41] reported that
color M-mode Doppler is a time-consuming
assessment and less sensitive in detecting milder
degrees of diastolic dysfunction in dialysis
patients.
It was reported that patients on HD have two
peculiar clinical features: anemia and AVF; both
factors lead to an increased preload on the right
heart chambers [42]. Although both factors are
present in our study group, no significant changes
on right heart volumes were noticed because vol-
umes return to normal ranges at the end of dialy-
sis treatment due to reduction of extracellular
fluid volumes others. Di Lullo et al. [43] found that
HD led to a reduction in TAPSE in patients with
AVF as opposed to central venous catheters due
to the effect of preload increase operated by
AVF. The current study enrolled patients with
AVF and found that RV systolic function assessed
by MPI and TAPSE was impaired in dialysis
patients, concordant with Floccari et al. [44], who
found that TAPSE was reduced <23 mm in 43%
of CKD patients.Conclusion
The mechanisms underlying development of
postcapillary PH in patients on dialysis are com-
plex. Further, prospective study utilizing right
heart catheterization should be conducted to char-
acterize patients with intrinsic increases in pul-
monary vascular resistance. Increased SPAP in
the HD population could be attributed to left
atrium dilatation, LV diastolic dysfunction, and
AVF, which causes volume overload.Acknowledgments
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